Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Susan Minton, D.O.
H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California
San Francisco, California, United States
- Bethesda Memorial Hospital Research Center
Boynton Beach, Florida, United States
- M.D. Anderson of Orlando
Orlando, Florida, United States
- Fawcett Memorial Hospital
Port Charlotte, Florida, United States
- Martin Memorial Cancer Center
Stuart, Florida, United States
- Tallahassee Memorial Healthcare, Inc.
Tallahassee, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- St. Joseph'S/candler
Savannah, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2006
- Primary completion
- 30 Apr 2011
- Completion
- 31 Aug 2012
- Last update posted
- 21 Nov 2014
- Registered enrollment
- 43
- Registry id
- NCT00365599
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.